vs
Side-by-side financial comparison of Enhabit, Inc. (EHAB) and JFrog Ltd (FROG). Click either name above to swap in a different company.
Enhabit, Inc. is the larger business by last-quarter revenue ($270.4M vs $145.3M, roughly 1.9× JFrog Ltd). JFrog Ltd runs the higher net margin — -10.5% vs -14.3%, a 3.8% gap on every dollar of revenue. On growth, JFrog Ltd posted the faster year-over-year revenue change (25.2% vs 4.7%). JFrog Ltd produced more free cash flow last quarter ($49.9M vs $3.3M). Over the past eight quarters, JFrog Ltd's revenue compounded faster (20.4% CAGR vs 1.5%).
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
JFrog Ltd is a global DevOps technology provider that delivers end-to-end software release, artifact management, and security solutions. It serves clients across tech, finance, retail, and manufacturing sectors, helping teams streamline development and delivery workflows for cloud, on-premises, and hybrid infrastructure.
EHAB vs FROG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.4M | $145.3M |
| Net Profit | $-38.7M | $-15.2M |
| Gross Margin | — | 77.9% |
| Operating Margin | -12.3% | -14.7% |
| Net Margin | -14.3% | -10.5% |
| Revenue YoY | 4.7% | 25.2% |
| Net Profit YoY | 15.9% | 34.4% |
| EPS (diluted) | $-0.76 | $-0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.4M | $145.3M | ||
| Q3 25 | $263.6M | $136.9M | ||
| Q2 25 | $266.1M | $127.2M | ||
| Q1 25 | $259.9M | $122.4M | ||
| Q4 24 | $258.2M | $116.1M | ||
| Q3 24 | $253.6M | $109.1M | ||
| Q2 24 | $260.6M | $103.0M | ||
| Q1 24 | $262.4M | $100.3M |
| Q4 25 | $-38.7M | $-15.2M | ||
| Q3 25 | $11.1M | $-16.4M | ||
| Q2 25 | $5.2M | $-21.7M | ||
| Q1 25 | $17.8M | $-18.5M | ||
| Q4 24 | $-46.0M | $-23.2M | ||
| Q3 24 | $-110.2M | $-22.9M | ||
| Q2 24 | $-200.0K | $-14.3M | ||
| Q1 24 | $200.0K | $-8.8M |
| Q4 25 | — | 77.9% | ||
| Q3 25 | — | 77.4% | ||
| Q2 25 | — | 76.3% | ||
| Q1 25 | — | 75.3% | ||
| Q4 24 | — | 75.4% | ||
| Q3 24 | — | 75.0% | ||
| Q2 24 | — | 78.8% | ||
| Q1 24 | — | 79.5% |
| Q4 25 | -12.3% | -14.7% | ||
| Q3 25 | 6.4% | -15.8% | ||
| Q2 25 | 6.3% | -20.4% | ||
| Q1 25 | 6.1% | -18.8% | ||
| Q4 24 | -16.0% | -21.9% | ||
| Q3 24 | -38.6% | -27.4% | ||
| Q2 24 | 4.3% | -18.6% | ||
| Q1 24 | 4.9% | -16.6% |
| Q4 25 | -14.3% | -10.5% | ||
| Q3 25 | 4.2% | -12.0% | ||
| Q2 25 | 2.0% | -17.0% | ||
| Q1 25 | 6.8% | -15.1% | ||
| Q4 24 | -17.8% | -20.0% | ||
| Q3 24 | -43.5% | -21.0% | ||
| Q2 24 | -0.1% | -13.9% | ||
| Q1 24 | 0.1% | -8.8% |
| Q4 25 | $-0.76 | $-0.13 | ||
| Q3 25 | $0.22 | $-0.14 | ||
| Q2 25 | $0.10 | $-0.19 | ||
| Q1 25 | $0.35 | $-0.16 | ||
| Q4 24 | $-0.92 | $-0.21 | ||
| Q3 24 | $-2.20 | $-0.21 | ||
| Q2 24 | $0.00 | $-0.13 | ||
| Q1 24 | $0.01 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $43.6M | $704.4M |
| Total DebtLower is stronger | $426.0M | — |
| Stockholders' EquityBook value | $534.0M | $887.4M |
| Total Assets | $1.2B | $1.3B |
| Debt / EquityLower = less leverage | 0.80× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $43.6M | $704.4M | ||
| Q3 25 | $56.9M | $651.1M | ||
| Q2 25 | $37.1M | $611.7M | ||
| Q1 25 | $39.5M | $563.5M | ||
| Q4 24 | $28.4M | $522.0M | ||
| Q3 24 | $45.7M | $467.8M | ||
| Q2 24 | $28.5M | $591.3M | ||
| Q1 24 | $36.5M | $579.6M |
| Q4 25 | $426.0M | — | ||
| Q3 25 | $441.5M | — | ||
| Q2 25 | $456.9M | — | ||
| Q1 25 | $467.3M | — | ||
| Q4 24 | $492.6M | — | ||
| Q3 24 | $502.9M | — | ||
| Q2 24 | $512.7M | — | ||
| Q1 24 | $526.7M | — |
| Q4 25 | $534.0M | $887.4M | ||
| Q3 25 | $566.8M | $859.4M | ||
| Q2 25 | $552.4M | $826.5M | ||
| Q1 25 | $543.2M | $800.0M | ||
| Q4 24 | $523.5M | $773.5M | ||
| Q3 24 | $566.1M | $756.2M | ||
| Q2 24 | $674.3M | $721.4M | ||
| Q1 24 | $672.3M | $707.8M |
| Q4 25 | $1.2B | $1.3B | ||
| Q3 25 | $1.2B | $1.3B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $1.2B | $1.2B | ||
| Q4 24 | $1.2B | $1.1B | ||
| Q3 24 | $1.3B | $1.1B | ||
| Q2 24 | $1.4B | $1.0B | ||
| Q1 24 | $1.4B | $997.1M |
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 0.83× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 0.89× | — | ||
| Q2 24 | 0.76× | — | ||
| Q1 24 | 0.78× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | $50.7M |
| Free Cash FlowOCF − Capex | $3.3M | $49.9M |
| FCF MarginFCF / Revenue | 1.2% | 34.3% |
| Capex IntensityCapex / Revenue | 0.4% | 0.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $65.8M | $142.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | $50.7M | ||
| Q3 25 | $37.8M | $30.2M | ||
| Q2 25 | $10.6M | $36.1M | ||
| Q1 25 | $17.9M | $28.8M | ||
| Q4 24 | $-4.1M | $49.1M | ||
| Q3 24 | $28.4M | $27.6M | ||
| Q2 24 | $9.6M | $16.7M | ||
| Q1 24 | $17.3M | $17.5M |
| Q4 25 | $3.3M | $49.9M | ||
| Q3 25 | $36.2M | $28.8M | ||
| Q2 25 | $8.7M | $35.5M | ||
| Q1 25 | $17.6M | $28.1M | ||
| Q4 24 | $-4.7M | $48.5M | ||
| Q3 24 | $27.7M | $26.7M | ||
| Q2 24 | $8.9M | $16.0M | ||
| Q1 24 | $15.5M | $16.6M |
| Q4 25 | 1.2% | 34.3% | ||
| Q3 25 | 13.7% | 21.0% | ||
| Q2 25 | 3.3% | 27.9% | ||
| Q1 25 | 6.8% | 23.0% | ||
| Q4 24 | -1.8% | 41.8% | ||
| Q3 24 | 10.9% | 24.5% | ||
| Q2 24 | 3.4% | 15.5% | ||
| Q1 24 | 5.9% | 16.6% |
| Q4 25 | 0.4% | 0.6% | ||
| Q3 25 | 0.6% | 1.0% | ||
| Q2 25 | 0.7% | 0.5% | ||
| Q1 25 | 0.1% | 0.5% | ||
| Q4 24 | 0.2% | 0.5% | ||
| Q3 24 | 0.3% | 0.9% | ||
| Q2 24 | 0.3% | 0.7% | ||
| Q1 24 | 0.7% | 0.8% |
| Q4 25 | — | — | ||
| Q3 25 | 3.41× | — | ||
| Q2 25 | 2.04× | — | ||
| Q1 25 | 1.01× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 86.50× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
FROG
Segment breakdown not available.
